A multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of daily oral administration of SH T00660AA for the treatment of endometriosis over 12 weeks
Latest Information Update: 22 May 2019
At a glance
- Drugs Dienogest (Primary)
- Indications Endometriosis
- Focus Registrational; Therapeutic Use
- Sponsors Bayer
- 22 May 2019 Results exploring variability in patient-reported pain and potential differential treatment response in clinical studies (study 307041 and 97085) among patients with endometriosis presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research
- 17 Nov 2005 New trial record.